The night time problems facing Parkinson's patients

CME Journal Geriatric Medicine

Volumn 8, Issue 3, 2006, Pages 99-103

  Porter, Bob ^a,b   Walker, R ^a  

^a NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Excessive daytime sleepiness; Parkinson's Disease; Sleep disturbances

Indexed keywords

AMITRIPTYLINE; ANTIHYPERTENSIVE AGENT; ANTIPARKINSON AGENT; APOMORPHINE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; CLOZAPINE; CORTICOSTERONE; DIAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; HYDROCORTISONE; LEVODOPA; MODAFINIL; OXYBUTYNIN; PRAMIPEXOLE; QUETIAPINE; SELEGILINE; TEMAZEPAM; THEOPHYLLINE; THYROID HORMONE; THYROXINE; TOLTERODINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZOPICLONE;

AKATHISIA; BLOOD DYSCRASIA; CONSCIOUSNESS DISORDER; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSKINESIA; GERIATRIC PATIENT; HALLUCINATION; HEALTH CARE NEED; HUMAN; INSOMNIA; MENTAL DISEASE; MOTOR DYSFUNCTION; NIGHT SLEEP; NOCTURIA; PARASOMNIA; PARKINSON DISEASE; PATHOPHYSIOLOGY; REVIEW; SEROTONIN SYNDROME; SLEEP DISORDER; VIVID DREAM;

EID: 33750485773     PISSN: 14751453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Schrag A, Ben Shlomo Y, Quinn N. How common are complications of Parkinson's disease? J Neurol 2002; 249: 419-23.
2. Lees AJ and Blackburn NA. The Nighttime Problems of Parkinson's disease. Clin Neuropharmacol 1988; 6: 512-9.
3. Tandberg E. and Larsen JP. A community-based study of Sleep disorders in Patients with Parkinson's disease. Mov Disord 1998; 13: 895-9.
4. Smith MC and Ellgring H. Sleep disturbances in Parkinson's disease patients and spouses. JAGS 1997; 45: 194-9.
5. Factor S, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effects in Parkinson's disease. Mov Disord 1990; 5: 280-5.
6. Partinen M. Sleep disorders related to Parkinson's disease. J Neurol 2004; 244(Suppl): S3-S6.
7. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psych 2000; 69: 308-12.
8. Rye DB and Jankovic J. Emerging views of dopamine in modulating sleep/ wake state from an unlikely source: Parkinson's Disease. Neurol 2002; 58: 341-6.
9. Askenasy JJM. Sleep in Parkinson's Disease. Acta Neurol Stand 1993; 87: 167-70.
10. Kales A and Ansel RD. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clin Pharm Ther 1971; 12: 397-406.
11. Olsson JE, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder demographic, clinical and laboratory findings in 93 cases. Brain 2000; 123 (part 2): 331-9.
12. Pappert EJ, Goetz CG, Niederman FG, et. al. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease. Mov Disord 1999; 14: 117-21.
13. Bhattacharya KF and Chaudhuri R. Are patients getting any rest from Parkinson's? Health and Ageing 2000; 22-4.
14. Chaudhuri R and Pal S. The Parkinson's Sleep Scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psych 2002; 73(6): 629-35.
15. Pal PK and Calne S. A review of normal sleep and its disturbance in Parkinson's disease. Parkinsonism and Related disorders 1998; 5: 1-17.
16. Sharf B and Moskovitz C. Dream phenomena induced by chronic levodopa therapy. J Neural Trans 1978; 43: 143-51.
17. Comella CL and Goetz, CG. Akathisia in Parkinson's disease. Mov Disord 1994; 9: 545-9.
18. Ford B. Pain in Parkinson's disease. Clin Neurosci 1998; 5: 63-72.
19. Rye DB and Bliwise DL. Movement disorders specific to Sleep and the Nocturnal Manifestations of Waking Movement disorders. Clin Disord 2000; 687-711.
20. Andreu N, Chale JJ, Senard JM. L-Dopa-induced sedation: a double blinded cross over controlled study versus triazolam and placebo in healthy volunteer. Clin Neuropharmacol 1999; 22: 15-23.
21. Bliwise DL. Sleep in normal ageing and dementia. Sleep 1993; 16: 40-81.
22. Williams RC, Karacan I, Hursch CJ. EEG of human sleep: clinical applications. New York: Wiley, 1974.
23. Goetz CG, Wilson RS, Tanner CM, Garron DC. Relationships among pain, depression, and sleep alterations in Parkinson's disease. Adv Neurol 1987; 45: 345-7.
24. Arnulf I. Parkinson's disease and sleepiness. An integeral part of PD. Neurol 2002; 58: 1019-24.
25. Comella CL. Sleep Disturbances in Parkinson's Disease. Curr Neurol Neurosci Rep 2003; 3: 173-80.
26. Chaudhuri KR. Nocturnal Symptom Complex in PD and its management. Neurol 2003; 61 (suppl 3): S17-S23.
27. Menza MA and Rosen RC. Sleep in Parkinson's disease. The role of depression and anxiety. Psychosomatics 1995; 36: 262-6.
28. British Medical Association. British National Formulary. 2006.
29. Arnulf I, Konofal E, Merino-Andreau M. Is excessive daytime sleepiness in Parkinson's disease related to poor sleep quality? An objective study of 47 patients. Neurol 2001; 56 (suppl 3): A307.
30. MacMahon DG. Excessive daytime sleepiness in PD. Geriatr Med 2006; 59-65.
31. Van der Kechove and Jacquy J. Sustained-release levodopa in parkinsonian patients with nocturnal disturbances. Neurol Belg 1993; 93: 32-9.
32. Chaudhuri R and Bhattacharya KF. The use of Carbergoline in nocturnal parkinsonian disabilities causing sleep disruption: a parallel study with controlled release levodopa. Eur J Neurol 1996; 6 (suppl 5): S11-S15.
33. Troster AI, Friedman JH, Lantigua R. Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentred clinical experience. Mov Disord 1998; 13: 377-82.
34. Reuter I and Ellis CM. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless leg syndrome. Acta Neurol Scand 1999; 100: 163-7.
35. Arnulf I and Bejjani BP. Improvement of Sleep Architecture with subthalamic nucleus stimulation. Neurol 2001; 55: 1732-4.
36. Garcia-Borreguero D. Parkinson's disease and sleep. Sleep Med Rev 2003; 7: 115-29.
37. Homann CN. Sleep attacks in patients taking dopamine agonists: review. BMJ 2002; 324: 1483-7.
38. Nielson AV. Treatment of Excessive daytime sleepiness in patients with Parkinson's disease with modafinil. Clin Neuropharmacol 2002; 25: 111-4.
39. Adler CH. Randomised Trial of Modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord 2006; 18: 287-93.